The FTC has requested that the court impose sanctions on notorious "pharma bro" Martin Shkreli for forming a new drug company in violation of a judge's ban. This order stemmed from a ruling that Shkreli oversaw an illegal scheme to maintain a monopoly on the life-saving drug Daraprim, and the FTC has asked the court to find Shkreli in civil contempt and impose a fine or other penalties. If found in contempt, Shkreli could face additional penalties.